Cassava’s disputed Alzheimer’s drug flops in end-stage trials
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Drugs
Health
Pharma